Swiss Life Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
4,753
-112
-2% -$5.31K ﹤0.01% 1493
2026
Q1
$251K Buy
4,865
+1,723
+55% +$121K ﹤0.01% 1230
2025
Q4
$290K Buy
+3,142
New +$301K ﹤0.01% 1041

Other funds holding INSP

Swiss Life Asset Management's INSP Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Inspire Medical Systems (INSP) stake by 2.3% in Q2 2026, selling an estimated $5.31K and leaving 4,753 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Swiss Life Asset Management first reported a position in INSP in Q4 2025 and has held it in 3 quarters since. The position peaked at $290K in Q4 2025. 163 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Swiss Life Asset Management held 4,753 shares of Inspire Medical Systems worth $212K as of Q2 2026.
  • Swiss Life Asset Management sold 112 Inspire Medical Systems shares in Q2 2026, an estimated $5.31K.
  • Inspire Medical Systems made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1493 holding.
  • Swiss Life Asset Management first reported a position in Inspire Medical Systems in Q4 2025 and has held it in 3 quarters since.
  • Swiss Life Asset Management's Inspire Medical Systems position peaked at $290K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.